APVO
Closed
Aptevo Therapeutics Inc
2.95
-0.10 (-3.28%)
Last Update: 01 Jul 2025 23:01:00
Yesterday: 3.05
Day's Range: 2.9451 - 3.1856
Send
sign up or login to leave a comment!
When Written:
2.035
Aptevo Therapeutics Inc is a biotechnology company that focuses on the development of novel immunotherapies for the treatment of cancer and other diseases. The company was founded in 2016 as a spin-off from Emergent BioSolutions Inc.
Aptevo's lead product candidate is APVO436, a bispecific antibody that targets CD123 and CD3, which is being developed for the treatment of acute myeloid leukemia (AML) and other hematological malignancies. The company is also developing a pipeline of other bispecific antibodies, as well as antibody-drug conjugates (ADCs) and other immunotherapies.
In addition to its oncology programs, Aptevo has a portfolio of products for the treatment of hemophilia and other bleeding disorders, including IXINITY, a recombinant factor IX therapy, and WinRho SDF, an intravenous immunoglobulin product.
Aptevo is headquartered in Seattle, Washington, and has a research and development facility in San Diego, California. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol APVO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Aptevo's lead product candidate is APVO436, a bispecific antibody that targets CD123 and CD3, which is being developed for the treatment of acute myeloid leukemia (AML) and other hematological malignancies. The company is also developing a pipeline of other bispecific antibodies, as well as antibody-drug conjugates (ADCs) and other immunotherapies.
In addition to its oncology programs, Aptevo has a portfolio of products for the treatment of hemophilia and other bleeding disorders, including IXINITY, a recombinant factor IX therapy, and WinRho SDF, an intravenous immunoglobulin product.
Aptevo is headquartered in Seattle, Washington, and has a research and development facility in San Diego, California. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol APVO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








